Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cytosorbents Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 60 | 2 | 53 | −5 |
| Shares | 14.9M | 36.0K | 14.7M | −165.6K (−1.1%) |
| Value | $20.7M | $49.4K | $22.7M | +$2.04M (+9.9%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Cytosorbents Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SEI Investments Co | 12,108 | $18.8K | 0.00% |
| Advisory Services Network, LLC | 2,200 | $3.41K | 0.00% |
| Park Place Capital Corp | 490 | $1.00K | 0.00% |
| GW&K Investment Management, LLC | 30 | $0 | 0.00% |
Sold out (9)
Institutions that held Cytosorbents Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Qube Research & Technologies Ltd | 31,434 | $43.0K |
| Winning Points Advisors, LLC | 22,900 | $33.0K |
| Two Sigma Advisers, LP | 16,600 | $23.0K |
| LMR Partners LLP | 14,709 | $20.0K |
| Goldman Sachs Group Inc | 11,618 | $16.0K |
| Commonwealth Equity Services, LLC | 10,129 | $13.0K |
| Brown Brothers Harriman & Co | 601 | $1.00K |
| Tower Research Capital LLC (TRC) | 958 | $1.00K |
| Ronald Blue Trust, Inc. | 218 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Cytosorbents Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 35,000 | $48.0K |
| American Portfolios Advisors | 1,000 | $1.36K |